Found: 4
Select item for more details and to access through your institution.
Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial.
- Published in:
- Diabetes Therapy, 2014, v. 5, n. 1, p. 267, doi. 10.1007/s13300-014-0072-0
- By:
- Publication type:
- Article
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 4, p. 1, doi. 10.1093/crocol/otad040
- By:
- Publication type:
- Article
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 9, p. 1347, doi. 10.1093/ecco-jcc/jjac048
- By:
- Publication type:
- Article
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 11, p. 1273, doi. 10.1093/ecco-jcc/jjw085
- By:
- Publication type:
- Article